ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma.
about
Molecular mechanisms of cisplatin resistance in cervical cancerCombination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1.Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
P2860
ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@ast
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@en
type
label
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@ast
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@en
prefLabel
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@ast
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
ERCC1 mRNA levels can predict ...... vical squamous cell carcinoma.
@en
P2093
Jian-li He
Yan-yang Wang
Zhou-lan Bai
P2860
P2888
P356
10.1186/1748-717X-7-221
P577
2012-12-23T00:00:00Z
P5875
P6179
1047992523